arrow
S

Subrata Ghosh

University College Cork
H指数:98
被引数:4.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bowel Urgency in Crohn’s Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Trial

克罗恩病中的肠道急迫感:美利曲珠单抗在随机对照III期试验中的效果

2025-07-140
OAAI
Endo-Histo foundational fusion model: a novel artificial intelligence for assessing histologic remission and response to therapy in ulcerative colitis clinical trial

内镜-组织学基础融合模型:一种用于评估溃疡性结肠炎临床试验中组织学缓解及治疗反应的新型人工智能

2025-07-018
OA
A Novel Switching of Artificial Intelligence to Generate Simultaneously Multimodal Images to Assess Inflammation and Predict Outcomes in Ulcerative Colitis—(With Video)

一种新型人工智能切换方法,用于同时生成多模态图像以评估溃疡性结肠炎中的炎症并预测结局——(附视频)

2025-06-160
OAAI
Exploring the connection between erythrocyte membrane fatty acid composition and oxidative stress in patients undergoing the Crohn's disease Therapeutic Diet Intervention (CD-TDI)

探索红细胞膜脂肪酸组成与克罗恩病患者接受克罗恩病治疗饮食干预(CD-TDI)时氧化应激之间的关联

2025-02-160
OA
Endo-Histo Foundational Fusion Model: A Novel Artificial Intelligence Approach for Predicting Histologic Remission and Early Response to Therapy in a Phase 2 Ulcerative Colitis Clinical Trial
2025-01-220
PRE
Sustained Improvements in Health-Related Quality of Life Outcomes With Long-Term Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Results from the FORTIFY Open-Label, Long-Term Extension

中度至重度活动性克罗恩病患者长期瑞萨基珠单抗治疗可带来持续改善的健康相关生活质量结局:FORTIFY开放标签长期扩展研究的结果

2024-12-010
OA
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective

在炎症性肠病的随机对照试验中定义粘膜愈合: 系统回顾和未来展望

2024-10-055
OA